Subclinical Hypothyroidism: Do You Need Levothyroxine?

Often not, at least not straight away. Subclinical hypothyroidism means your TSH is above the normal range while your free T4 is still normal. Guidelines advise repeating the test first, because a mildly raised TSH often settles on its own. Large trials found that levothyroxine for a TSH under 10 brought the number down but did not ease tiredness or improve quality of life for most adults. Doctors are more likely to recommend it when TSH is above 10, during pregnancy planning, or when TSH keeps rising.

If your report came back flagged and you already feel flat, "wait and see" can sound like being brushed off. Here is what the result means, what the research shows, and how to talk with your GP about whether treatment makes sense for you.

What subclinical hypothyroidism means

A standard thyroid test usually looks at two numbers. TSH is the signal from the pituitary gland asking your thyroid to work. Free T4 is the main hormone your thyroid makes. In subclinical hypothyroidism, TSH sits above the range printed on your report, but free T4 is still within it. Put simply, your thyroid is being asked to work a little harder to keep its output normal.

"Subclinical" describes the pattern on paper, not how you feel. Some people have symptoms and many have none. When free T4 also drops below its range, that is overt hypothyroidism, which is treated. Our guide to TSH, T4 and T3 explained walks through each test.

Doctors often split subclinical hypothyroidism into a mild form, with TSH up to about 10, and a more marked form above 10. According to the European Thyroid Association, around 9 in 10 cases are the mild kind.

Why one result isn't a diagnosis

TSH moves around more than most people realise. It runs higher in the evening and overnight than in the early afternoon, and its daily rhythm shifts with night shifts and irregular sleep. It can rise for a while as you recover from an illness, and some medicines, such as lithium and amiodarone, push it up. High-dose biotin supplements can distort the test itself; our article on biotin and thyroid test results explains why.

TSH also rises with age. In a large US survey of people without thyroid disease, the top of the healthy range was about 3.6 for people in their twenties and about 7.5 for people over 80. Some Australian pathology services use age-related ranges for this reason. Our guide to what a normal TSH range really means covers this in more detail.

That is why Australian and international guidance says not to act on a single result. The Medical Journal of Australia's GP guidance suggests repeating TSH 6 to 8 weeks later, along with free T4 and thyroid antibodies. The RACGP suggests two to three months, and advises delaying the test if you are acutely unwell. UK guidance looks for two raised results three months apart before considering treatment.

The repeat often looks different: the same MJA guidance notes that a mildly raised TSH returns to normal without treatment in more than half of people.

How common is it, and does it turn into an underactive thyroid?

It is common. Studies put it at somewhere around 4 to 10 in every 100 adults, depending on the population and the cut-off used, and it becomes more common with age. The most frequent cause of a persistently raised TSH is Hashimoto's, the autoimmune form of thyroid disease.

Most people with a mildly raised TSH never go on to a fully underactive thyroid. Two things make it more likely: how high the TSH is, and whether thyroid antibodies are present.

• The TSH level: in a Swiss study that followed 82 people for about nine years, none with a starting TSH of 4 to 6 developed overt hypothyroidism within 10 years. About 4 in 10 with a TSH of 6 to 12 did, and about 3 in 4 with a TSH above 12. The authors noted that a large group simply stayed in the mild range.
• Antibodies: in the same study, progression was more common with positive TPO antibodies (about 6 in 10) than without them (about 2 in 10). The 20-year Whickham study in the UK found that a raised TSH and positive antibodies each raised the chance of a later underactive thyroid, and having both raised it most.

If you have positive antibodies, our article on high thyroid antibodies explains what they do and don't tell you.

Does levothyroxine help? What the trials found

• The TRUST trial (2017): 737 adults aged 65 and over with a persistently raised TSH and normal free T4 took levothyroxine or a placebo for a year. Levothyroxine brought TSH down, but there was no difference in hypothyroid symptoms or tiredness between the two groups.
• Adults over 80 (2019): a combined analysis of two trials found the same. Symptom scores shifted by about the same small amount on placebo as on levothyroxine.
• The big picture (2018): a meta-analysis of 21 trials with about 2,200 adults found that treatment brought TSH into range but did not improve quality of life or thyroid-related symptoms. The authors concluded the findings do not support routine treatment. An earlier Cochrane review of 12 smaller trials reached a similar conclusion.

In 2019 an international panel writing in the BMJ made a strong recommendation against thyroid hormone for most adults with subclinical hypothyroidism. It said the advice does not apply to people trying to conceive or with a TSH above 20, and may not apply to people with severe symptoms or young adults, around 30 and under.

The evidence has limits. Most trial participants were older with only a mild rise (the average starting TSH in TRUST was about 6.4), and the MJA guidance notes any benefit is probably greater in younger and middle-aged people. Treatment has downsides too: usually a daily tablet for life, and, according to the RACGP, too high a dose that pushes TSH below range is linked with heart rhythm problems and weaker bones.

A flagged TSH is a reason to look again, not a verdict. The decision about treatment belongs to you and your doctor, together.

When doctors usually do recommend treatment

Guidelines agree that some situations are different. Your doctor is more likely to suggest levothyroxine if:

• Your TSH is above 10 on repeat tests. The MJA guidance says treatment is indicated at this level. The RACGP suggests considering it when TSH is above 10 on two tests three months apart and you have symptoms, and the European guideline recommends it for people under 65 even without symptoms.
• Your TSH keeps climbing. For people with positive antibodies, the RACGP suggests repeat tests at three months, six months and then yearly, with treatment if TSH rises steadily or symptoms develop.
• You are younger and have symptoms. UK guidance suggests considering a six-month trial for adults under 65 with symptoms and a mildly raised TSH on two occasions. The RACGP also lists positive antibodies, higher heart risk, and previous thyroid surgery or radioactive iodine as reasons to consider a trial.
• You have a goitre (an enlarged thyroid), or have had part of your thyroid removed. The European guideline recommends treating persistent subclinical hypothyroidism in both situations.
• You are pregnant or planning a pregnancy. Your doctor will use different targets, so tell them early.

Age can tip the other way. For people over about 80 with a TSH up to 10, the European guideline suggests careful watching rather than treatment.

What a trial of treatment looks like, and how to judge it honestly

For a younger person with a mildly raised TSH and real symptoms, many doctors offer a time-limited trial. The MJA guidance describes a three-month trial as reasonable. The European guideline suggests reviewing symptoms three or four months after TSH has come into range, and UK and RACGP guidance suggest considering stopping if symptoms persist once TSH is in range, and looking for another cause.

Judging a trial is harder than it sounds. Symptoms come and go on their own, and expectations matter. In one double-blind study of people already on levothyroxine, participants could not tell how their dose had been changed, yet preferred the dose they believed was higher.

A few things can make the trial fairer:

• Before starting, write down the two or three symptoms that bother you most and rate each one.
• Agree with your GP when you will review, and what would count as a real change.
• Have your TSH rechecked as your doctor advises, usually about six to eight weeks after starting or changing a dose.
• At the review, compare your ratings honestly and decide together whether to continue. Never stop or change the dose on your own.

If you do start, take the tablet with water on an empty stomach and wait at least 30 minutes, preferably 60, before food. Keep calcium, iron and other mineral supplements several hours away, around four.

If you feel unwell, what else to check

The RACGP's information for the public puts it plainly: with a slightly raised TSH, your thyroid is not usually the cause of symptoms like tiredness, low mood and weight change. That doesn't make the symptoms less real. It means they deserve a proper look.

healthdirect lists common causes of fatigue that are worth ruling out, including anaemia or low iron, sleep problems such as insomnia or sleep apnoea, stress, anxiety and depression, diabetes, and some medicines. Australian GP guidance also names coeliac disease and pernicious anaemia, a cause of low vitamin B12, both of which are more common alongside autoimmune thyroid disease. Low vitamin D has also been linked with autoimmune thyroid disease, though a link is not proof of cause.

Our guides to iron and ferritin and what else to check when you're still tired go through these, and our overview of hypothyroidism symptoms explains which point to the thyroid. The RACGP also suggests a look at sleep, activity, alcohol, stress and everyday eating. healthdirect advises seeing your doctor if fatigue lasts more than two weeks and isn't getting better.

Frequently asked questions

What TSH level counts as subclinical hypothyroidism?

It means a TSH above the range on your own report, often around 4, with free T4 still in range. Doctors usually call a TSH up to about 10 mild and above 10 more marked. Ranges differ between pathology services and rise with age, so always read your result against your own report.

Can subclinical hypothyroidism go away on its own?

Yes, often. Australian GP guidance notes that a mildly raised TSH returns to normal without treatment in more than half of people, which is why the test is usually repeated after six weeks to three months before any decision is made.

Will levothyroxine fix my tiredness if my TSH is slightly high?

For most adults with a mild rise, trials found levothyroxine lowered TSH but did not improve tiredness or quality of life more than a placebo. Some doctors still offer a time-limited trial to younger people with clear symptoms. It is worth discussing with your GP, alongside checks for other causes of tiredness.

Should I be on levothyroxine if my TSH is over 10?

Most guidelines suggest treatment is considered when TSH stays above 10 on repeat tests, particularly in people under 65 or with symptoms. The final decision depends on your age, symptoms and health, so talk it through with your doctor.

How often should subclinical hypothyroidism be checked if it isn't treated?

The RACGP suggests repeat tests at three months, six months and then yearly if you have positive antibodies. UK guidance suggests yearly checks if there are signs of underlying thyroid disease and every two to three years if not. Retest sooner if symptoms change, but no sooner than six weeks after the last test.

The honest takeaway

A slightly high TSH with a normal free T4 is common and often temporary, and for most adults treatment has not been shown to make people feel better. That is why the usual first step is a repeat test, not a prescription. Treatment becomes more likely when TSH is above 10 or keeps climbing, with a goitre or after thyroid surgery, or when planning a pregnancy, and a time-limited trial can be reasonable for younger people with real symptoms. If you feel unwell, keep looking for the cause with your doctor, and make each decision together.

ThyroBase is a nutritional supplement and is not intended to diagnose, treat, cure, or prevent any disease. It is designed to sit alongside your thyroid medication, not replace it. This article is general information, not medical advice. Never start, stop or change a supplement or prescription medication without speaking to your doctor or pharmacist first.

References

Bekkering GE, Agoritsas T, Lytvyn L, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019;365:l2006.
Feller M, Snel M, Moutzouri E, et al. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA. 2018;320(13):1349-1359.
Stott DJ, Rodondi N, Kearney PM, et al. Thyroid hormone therapy for older adults with subclinical hypothyroidism. New England Journal of Medicine. 2017;376(26):2534-2544.
Mooijaart SP, Du Puy RS, Stott DJ, et al. Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism. JAMA. 2019;322(20):1977-1986.
Villar HC, Saconato H, Valente O, Atallah AN. Thyroid hormone replacement for subclinical hypothyroidism. Cochrane Database of Systematic Reviews. 2007;(3):CD003419.
Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. European Thyroid Journal. 2013;2(4):215-28.
Walsh JP. Managing thyroid disease in general practice. Medical Journal of Australia. 2016;205(4):179-84.
Huber G, Staub JJ, Meier C, et al. Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. Journal of Clinical Endocrinology and Metabolism. 2002;87(7):3221-6.
Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology. 1995;43(1):55-68.
Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism. 2007;92(12):4575-82.
Samuels MH, Kolobova I, Niederhausen M, et al. Effects of altering levothyroxine (L-T4) doses on quality of life, mood, and cognition in L-T4 treated subjects. Journal of Clinical Endocrinology and Metabolism. 2018;103(5):1997-2008.
The Royal Australian College of General Practitioners. First do no harm: management of subclinical hypothyroidism (GP and consumer guides). 2022.
National Institute for Health and Care Excellence. Thyroid disease: assessment and management (NG145). 2019, updated 2023.
healthdirect Australia. Hypothyroidism; Fatigue. healthdirect.gov.au.